EUR 1.32
(10.92%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | - USD | -100.0% |
2022 | 355.59 Thousand USD | 0.0% |
2021 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 FY | - USD | -100.0% |
2023 Q1 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 FY | 355.59 Thousand USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
BioNTech SE | 219.1 Million EUR | 100.0% |
CureVac N.V. | 41.85 Million EUR | 100.0% |
Biotest Aktiengesellschaft | 689.8 Million EUR | 100.0% |
Biotest Aktiengesellschaft | 689.8 Million EUR | 100.0% |
BRAIN Biotech AG | 4.65 Million EUR | 100.0% |
Formycon AG | 29.48 Million EUR | 100.0% |
Heidelberg Pharma AG | 5.83 Million EUR | 100.0% |
Medigene AG | 2.95 Million EUR | 100.0% |